Metrics In Balance (MLMIB) | Stock Overview & Key Data
Metrics In Balance Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €7.50 on May 13, 2019
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2022
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Metrics In Balance
MLMIB
|
144.89K Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -90.00% | -97.93% | -99.50% | -99.50% | -99.50% |
| 182.02M Mid-cap | 3.14% | -9.87% | 3.14% | -1.00% | 3.35% | -19.76% | -22.66% | -52.13% | 25.60% | 265.12% | 265.12% | |
|
Laboratoires
ALEMG
|
13.88M Small-cap | -1.20% | -1.20% | 4.88% | 25.70% | 26.02% | 18.07% | 8.41% | -70.23% | -17.37% | 0.00% | 0.00% |
|
Sanofi
SAN
|
N/A | -1.47% | 2.14% | -7.77% | -7.77% | -7.77% | -6.59% | -6.59% | -6.59% | -6.59% | -6.59% | -6.59% |
|
TheraVet S.A
ALVET
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -89.74% | -98.11% | -99.02% | -99.02% | -99.02% | -99.02% |
| 88.12B Large-cap | 6.30% | 6.23% | -6.90% | -6.90% | -6.90% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% |
Ownership & Short Interest
Calculate Your Metrics In Balance Investment Returns
Long-Term Investment Performance Analysis
Metrics In Balance stock price in Mar 2018 was €6.00, A €1,000.00 lump sum investment in Metrics In Balance made 8 years ago would be worth approximately €5.00 today, representing a negative return of -99.50%. This translates to an annualized return (CAGR) of -47.46%.
8 Years 2 Months Investment Scenario (Mar 2018 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MLMIB's 52-week high and low?
- In the last 52 weeks, Metrics In Balance reached a high of €0.03 (on June 12, 2026) and a low of €0.03 (on June 12, 2026).
- What is the market cap and P/E ratio for MLMIB?
- Curious about Metrics In Balance's size and valuation? Its market capitalization stands at 144.89K. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does MLMIB pay dividends? If so, what's the yield?
- As for dividends, Metrics In Balance isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Metrics In Balance's main competitors or similar companies to consider before investing?
When looking at Metrics In Balance, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Bastide le Confort
BLC182.02M Healthcare Medical Distribution -19.76% -22.66% Laboratoires
ALEMG13.88M Healthcare Medical Distribution 18.07% 8.41% Sanofi
SANN/A Healthcare Drug Manufacturers - General -6.59% -6.59% TheraVet S.A
ALVETN/A Healthcare Biotechnology -89.74% -98.11% EssilorLuxottica
EL88.12B Healthcare Medical Instruments & Supplies -6.21% -6.21% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Metrics In Balance S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Metrics In Balance's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.08%, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MLMIB?
- Looking at Metrics In Balance's growth, its revenue over the trailing twelve months (TTM) was €30K. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of MLMIB stock is held by insiders and institutions?
- Wondering who owns Metrics In Balance stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.